Please assess the completion status of the following clinical trial:

Trial Title: A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects who are diagnosed with AD in accordance with the criteria of the Japanese Dermatological Association~* Subjects whose AD affects 5% to 40% of BSA (excluding scalp) at the screening and baseline examinations~* Subjects who have an IGA score of 2 or 3 at the screening and baseline examinations~Exclusion Criteria:~-Subjects who have an AD or contact dermatitis flare-up defined as a rapid intensification of AD, within 28 days prior to the baseline examination

- Gender: ALL
- Minimum Age: 3 Months
- Maximum Age: 2 Years
- Healthy Volunteers: f

Study Arms:
- OPA-15406 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).